type full_text History And Physical Findings [REDACTED] [REDACTED][REDACTED]Â [REDACTED_PASSPORT]Â 89 YO FÂ DA: AtenololÂ Lives together with sonÂ wheelchair boundÂ .PMHxÂ 1) HTNÂ 2) Iron deficiency anaemiaÂ Hb 9 10 since Mar 2020Â 3) DM 6.5 March 2021Â 4) AF with tachy bradyÂ Echo EF 45 with global LV hypokinesiaÂ on ApixabanÂ 5) Subclinical hypothyroidism vs. possible non thryoidal illnessÂ followed up with AIM clinic: TFT normalized no need for further recheckÂ 6) CKD baseline Cr 130 s 140 sÂ .Chronic Meds:Â PO APIXABAN TabletÂ 2.5 MG 2 times a day 2 MONTHSÂ Â Â Â PO MECOBALAMIN CapÂ 500 MCG every morning 2 MONTHSÂ Â Â Â PO SANGOBION CapÂ 1 CAP 2 times a day 2 MONTHSÂ restart on 1/4/2021, 1 wk post ferinject Â PO FRUSEMIDE TabletÂ 40 MG twice a day at 8 am and 4 pm 2 MONTHSÂ Â Â Â PO POTASSIUM CHLORIDE TabletÂ 600 MG every morning 2 MONTHSÂ Â Â Â Topical MICONAZOLE CreamÂ 1 APPLY 2 times a day 1 WEEKÂ Â Â Â PO NEPRO HP Liquid Enteral FeedÂ 110 ML 2 times a day 2 MONTHS AND 8 am, 3 pm Â PO NEPRO HP Liquid Enteral FeedÂ 220 ML 2 times a day when necessary 2 MONTHSÂ if eating lt 1/2 share, (12 noon and 6 pm) Â .Â Last discharged from NUH on 25/3/2021 for:Â 1. ADHF likely 2' severe TR (functional)Â also contributed by bradycardiaÂ Elevated trops likely trop leak: 246 gt 228 gt 256Â gt bg known AF with tachybrady EF 45 with global LV hypokinesia Â gt baseline Lasix 40 mg OM outpatient weight 70.6 kg (apr 2020)Â given IV Lasix 40 mg BD, and subsequently oralised Â repeat TTE this admission (19/3): LVEF 55 , multiple RWMA, severe TR, PASP 50 Â . Â complicated by Â (A) AoCKD likely Cardiorenal Â Cr 206 on admission baseline Cr 130 s 140 s Â .Â 2. Combined sinus and AV node dysfunction (AF with CHB with Junctiona Escape Rhythm)Â Holter monitoring: AF with with episodes of regularized AF likely CHB with junctional escape rhythmÂ gt bg known hx of AF with tachybradyÂ digoxin stopped since 2020 electrolytes NADÂ Reviewed by EP Combined sinus and AV node dysfunction (AF with CHB with JER)Â gt offered PPM and/or CRT not keen to proceed with procedure Â thyroid panel NADÂ . Â 3. Stable MCHC anemiaÂ Hb 9 10 since Mar 2020Â known history of Fe def anemia on supplementationÂ gt B 12/folate repleteÂ Iron panel (18/3): Ferritin 17 Iron sat 28 , Vit B 12 and folate replete Â explored further endoscopic evaluation with family on 22/3/2021 Â gt in view of stable counts/ nil active bleeding, not for scopes at present Â gt understands risk of missed malignancyÂ IV Ferrinject 500 mg once given on 24/3/2021 Â .Â 5. Social issues Â case manager review lack of care at home son not taking care of her well defaulted medications for the past 5 months defaulted appointments as wellÂ reviewed by MSW inpatient Â gt Â Â Care plan is for [REDACTED] with daughter in [REDACTED] Mdm [REDACTED] [REDACTED] [REDACTED] [REDACTED][REDACTED] as carer during post daycare hours.Â .Â Last seen by CVM on 14/4/2021: Frusemide 40 mg OM and 40 mg every evening PRNÂ gt no leg edema at that timeÂ .HOPCÂ transferred from NUH A amp E s/t daughter at bedside for historyÂ functional decline x 1/7Â a/w diaphoresis 1 episode, ?chest pain having foul smelling urine, but patient doesnt complain of dysuria patient complaining of R knee pain and back pain longstanding main carer is daughter, gives about 800 ml/day for liquids knows was told to give furosemide 40 mg ON PRN if no swelling however last 4 days not given any furosemideÂ otherwise all other medications serving as instructed no diarrhoea, no constipation CARE status discussed not for CPR/intubation/icu transfer/vasopressors . No fevers, no ARI sx No family members in high risk jobs No visits to TTSH recently, no recent travel hx Has 2 grandchildren with ARI sx put on 5 days MC, no COVID swab done Â .Â Vitals in ED: T 36.4, HR 98, BP 166/85, RR 28 SPO2 97 RAÂ Vitals in ward: T 36.8 HR 113 BP 157/92 RR 22 SPO2 94 RAÂ .O/eÂ Alert, conversantÂ speaking in full sentences JVP elevatedÂ H S 1 S 2Â L bibasal coarse creps up to mid zoneÂ A SNT BS Â Calves supple, nil pedal oedemaÂ Bedside US in ED: Â no d shaped septum Â abdo aorta obscured by significant bowel shadowing but what is seen is not dilated. Â IVC fully distended 2.0 2.1 cm, minimal respiratory variation Â .Progress in ED:Â Labs UC 10 CXR CTBÂ CARE Form 1 4Â IV furosemide 40 mg Once 1847Â .Investigations:Â ECG Â eGFR 26Â Cr 146 lt 152Â Urea 13.8 lt 18.2 Â Na 19Â K 4.7Â ECG A.fibÂ Trop 120.2 lt 120.4Â TW 11.32 Â Hb 11.5 lt 10.5Â PLT 207Â CTB: Â 1) No acute intracranial haemorrhage or established territorial infarct is detected.Â 2) Old infarcts in the right occipital lobe and bilateral centrum semiovale, new since the prior CT in 2019. Â . Issues and Progress 1. Pneumonia on b/g swallowing impairment, recent stroke (see point 3) Cx fast AF, HR 140 s fluid responsive hypotension 70/40 gt 146/64 after 500 ml fluid bolus TW 11 with neutrophilia Tmax 37.9 (on 9/5/21), desaturated to NRM (despite diuresis 2 L on 8/5/21) CXR fluid OL . 2. Decompensated ADHF on b/g of severe TR LVEF 55 Severe TR on TTE Mar 2021 On baseline Lasix 40 mg OM then 40 mg ON PRN leg swelling DW 68.7 kg (Mar 2021) CXR fluid OL Trop I 120 gt 120 gt 697 ECG fast AF TW 11 neutrophilia, no fever or signs of sepsis . 3. Acute/Subacute occipital stroke CT brain: Right occipital lobe with loss of grey white matter differentiation is more in keeping with an acute/sub acute infarct Pt has AF on apixaban . Events leading to demise on 9/5/21 Pt became increasingly lethargic and drowsy Visual impairment progressed (likely related to point 3) BP dropped to 70/40 Minimally fluid responsive Fast AF 140 150 s Lactate up to 7 Desaturated to require NRM . Discussed with family Goals of care for comfort CARE form 1 7 Pt kept comfortable . Patient was passed away on 9/5/21 at 1218 pm Condolences offered to familyCCOD Stroke eCCOD Application No.: [REDACTED_CASE_REF] Outcome Followup Plan NUH Cardio 13/10/21